COMMUNIQUÉS West-GlobeNewswire

Dr. Alfredo Hoyos Opens First InMode International BodyTite Training Center
09/02/2018
LAKE FOREST, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- InMode Aesthetic Solutions, a leader in aesthetic medicine and technology, is proud to announce the opening of the first official International InMode BodyTite [...]
Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor
09/02/2018
--Enrollment target reached; topline data on track for Q3 2018 announcement-- NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ: AQXP ), a clinical-stage pharmaceutical [...]
Globus Medical Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call
09/02/2018
AUDUBON, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December [...]
HMS Holdings Corp. To Report Fourth Quarter and Full Year 2017 Financial and Operating Results
09/02/2018
IRVING, Texas, Feb. 09, 2018 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (NASDAQ: HMSY ) today announced it will report fourth quarter and full year 2017 financial and operating results at 7:30 am CT / 8:30 am ET on Friday, [...]
Auris Medical Announces Extraordinary General Meeting of Shareholders
09/02/2018
Proposed capital restructuring to ensure compliance with Nasdaq minimum bid price rule contingent on Company's share price development Alain Munoz proposed as new member of the Board of the Directors Zug, Switzerland, [...]
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference
09/02/2018
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference Two Phase 1 trials to start in 2018 for A 2A receptor antagonist and [...]
Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
YARDLEY, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive [...]
Ogilvy CommonHealth Worldwide’s Reilly and Logan Inducted Into the Medical Advertising Hall of Fame's Future Famers Program
09/02/2018
PARSIPPANY, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced Lindsey Reilly, senior [...]
LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018
09/02/2018
BURLINGTON, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will release its fourth quarter 2017 financial results on Wednesday, February 21, 2018, after the [...]
Immune Design to Present at Upcoming Investor Conferences
09/02/2018
SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), an immunotherapy company focused on next-generation therapies in oncology, today announced that senior management [...]
The American Health Council Appoints Michael Mahla, MD to Physician Board
09/02/2018
NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Michael Mahla, MD is selected to the American Health Council’s Board of Physicians for his outstanding contributions to the medical field. As a professor and executive vice [...]
Enhanced MuScreen™ Platform Revolutionizes Preclinical Development of Immunotherapeutics
09/02/2018
SAN DIEGO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
Catalyst Biosciences Announces Positive Top-Line Data from Phase 1/2 Study of Subcutaneous CB 2679d/ISU304 in Individuals with Hemophilia B
09/02/2018
All individuals with severe hemophilia improved to mild hemophilia activity levels after only six daily doses with a continuous linear increase in Factor IX clotting activity These results suggest that long-term dosing [...]
Summit Therapeutics to Participate in Upcoming Investor Conferences
09/02/2018
Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES Oxford, UK, 9 February 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug [...]
Summit Therapeutics to Participate in Upcoming Investor Conferences
09/02/2018
OXFORD, United Kingdom, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, [...]
Bio-Path Holdings Announces 1-for-10 Reverse Stock Split
09/02/2018
HOUSTON, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock
09/02/2018
MEDFORD, N.Y., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today the pricing of its previously [...]
Lotus Enters “Active Review” with Health Canada & Closes Cannabis Financing of $1 Million
09/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc (CSE:J) (the " Company ") announced today that [...]
pSivida to Present at the 2018 BIO CEO & Investor Conference
09/02/2018
WATERTOWN, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President [...]

Pages